Can an ARB be given to patients who have had angioedema on an ACE inhibitor? | Cleveland Clinic Journal of Medicine
ARBs in hypertension - The British Journal of Cardiology
Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia | Hypertension
Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports
Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ: Vascular Health and Risk Management: Vol 7
Is an ACE inhibitor plus an ARB more effective than either drug alone? | Cleveland Clinic Journal of Medicine
Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials | PLOS ONE
Costs and benefits of ARBs in practice - The British Journal of Cardiology
Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials | PLOS ONE
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 | NEJM
Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials | PLOS ONE
Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome | Journal of Translational Medicine | Full Text
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library
Arboricultural Association - Membership Information
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
Is an ACE inhibitor plus an ARB more effective than either drug alone? | Cleveland Clinic Journal of Medicine
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial - The Lancet Respiratory Medicine
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) | Journal of the American College of Cardiology
Frontiers | Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea | Scientific Reports
Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers | AAFP
Frontiers | Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery
Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria | Hypertension
Pregnancy protection and pregnancies in women prescribed ACE inhibitors or ARBs: a cross-sectional study in primary care
The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension | PLOS ONE
